Search results for ''
New release of neXtProt with ENYO Pharma human interactome data
ENYO Pharma and the CALIPHO group at SIB Swiss Institute of Bioinformatics are pleased to announce the neXtProt data release 2020-07-17, that integrates the human protein interactome curated by the company as “GOLD” data. This dataset includes 108,000 descriptions of protein interactions from 324 papers with the capture of the experimental method (PSI-MI). When the sequence used in the protein-protein interaction experiment is known, this information has been collected and is available in neXtProt as interaction mapping annotations.
ENYO Pharma selected in the FrenchTech 120
ENYO Pharma is proud to be part of the FrenchTech 120 with such promising companies. It is a strong recognition from the French State.
J.P. Morgan 2020 – 38th Annual Healthcare Conference
January 13-16, 2020
San Francisco, USA
“ENYO Pharma team was present at San Francisco during the J.P. Morgan conference, which is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.”
ENYO Pharma new headquarters opening
On the 18th of November, 2019 ENYO Pharma and Edelris inaugurated their new main offices in the Laënnec Bioparc located in Lyon. It was a great moment and we had the honor to host Mr. David Kimelfeld (Metropolis President) and Mr. Michel Le Faou (Municipal Councilor representing the mayor of the 8th arrondissement) for our “biotechnologies and territory development” round table. This new headquarter localization will open promising horizons for collaborations and contribute to ENYO’s growth.
Latest Press Release 